Press release

Following U.S. Success, CooperVision's Brilliant Futures™ Myopia Management Program Expands Globally

UK, Russia, Spain, Portugal, Canada, South Korea and Taiwan Adopt the Comprehensive Approach SAN RAMON, Calif., Nov. 10, 2020 /PRNewswire/ -- Less than a year

articleThe Cooper Companies, Inc.November 10, 20203/company/the-cooper-companies-inc/news/following-us-success-coopervisions-brilliant-futurestm-myopia-management-program
Following U.S. Success, CooperVision's Brilliant Futures™ Myopia Management Program Expands Globally

About this update from The Cooper Companies, Inc.

[{"type":"text","content":"UK, Russia, Spain, Portugal, Canada, South Korea and Taiwan\n Adopt the Comprehensive Approach\n\n\nSAN RAMON, Calif., Nov. 10, 2020 /PRNewswire/ -- Less than a year after debuting its Brilliant Futures™ Myopia Management Program featuring the MiSight® 1 day contact lens in the United States, CooperVision is now expanding the comprehensive approach to multiple countries, including the United Kingdom, Russia, Spain, Portugal, Canada, South Korea, and Taiwan. This seeks to create a new standard of care by creating the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty.\n\n \n \n \n \n \n \n\n \n\"Several years from now, I believe we will look back at late 2020 as an inflection point in the global myopia management movement,\" said Dan McBride, President of CooperVision. \"Never before has there been this degree of momentum, driven in large part by substantial investments CooperVision is making in evidence-based science, innovative products, and comprehensive clinical and practice management education in the form of Brilliant Futures™. Partnering with the optometry, ophthalmology and pediatric health communities, we have a real opportunity to change the lives of countless children in the decades ahead.\"\nBrilliant Futures™ has attracted robust participation during its selective U.S. rollout, with more than 1,500 eye care professionals now certified to fit MiSight® 1 day. The innovative lens is the first and only soft contact lens the U.S. Food and Drug Administration has approved* for slowing the progression of myopia in children, who at initiation of treatment are 8-12 years of age.[1] During the past several weeks, a nationwide parent-focused advertising campaign featuring entrepreneur and actress Sarah Michelle Gellar—believed to be possibly the world's largest-ever consumer myopia management awareness initiative—further accelerated adoption.\nComplementing that success, Brilliant Futures™ is now coming to countries where MiSight® 1 day has been previously available, such as the United Kingdom in October. Indie Grewal, Optometrist and President of the British Contact Lens Association (BCLA), says myopia management \"has the potential to revolutionize clinical outcomes and can allow us to change the trajectory of childhood myopia in practice.\" The program will also be introduced this month...

More updates from The Cooper Companies, Inc.